Evaluation of the usefulness of anti-glyceraldehyde-3-phosphate dehydrogenase antibodies as a treatment for invasive candidiasis in a murine model

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 89, Issue 3-4, 2006, Pages 345-350

  Gil, María Luisa ^a   Dagan, Shlomo ^b   Eren, Rachel ^b   Gozalbo, Daniel ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b XTL Biopharmaceuticals Ltd Israel   (Israel)

Author keywords

Anti GAPDH antibodies; Candida albicans; Glyceraldehyde 3 phosphate dehydrogenase; Immunization; Immunoprotection; Murine candidiasis

Indexed keywords

CELL MEMBRANE PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE ANTIBODY; GLYCOPROTEIN E2; IMMUNOMODULATING AGENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY; IMMUNIZATION; PHOSPHATE;

ACTIVE IMMUNIZATION; ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGAL CELL; FUNGAL VIRULENCE; IMMUNOTHERAPY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TARGETING; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMMUNIZATION; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED ICR; RABBITS;

CANDIDA ALBICANS; MURINAE;

EID: 33745154103     PISSN: 00036072     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10482-005-9037-7     Document Type: Article

References (24)

1. Argiro L., Henri S., Dessein H., Kouriba B., Dessein A.J. and Bourgois A. 2000. Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorbtion with GM-CSF on alum. Vaccine 18: 2033-2038
2. Bromuro C., Torosantucci A., Chiani P., Conti S., Polonelli L. and Cassone A. 2002. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immun. 70: 5462-5470
3. Calderone R.A. 2002. Candida and Candidiasis. 3rd ed. ASM Press, Washington
4. Cardenas-Freitag L., Cheng E., Mayeux P., Domer J.E. and Clements J.D. 1999. Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect. Immun. 67: 826-833
5. Chaffin W.L., López-Ribot J.L., Casanova M., Gozalbo D. and Martínez J.P. 1998. Cell wall and associated proteins in Candida albicans: Identification, function, and expression. Microbiol. Mol. Biol. Rev. 62: 130-180
6. Delgado M.L., Gil M.L. and Gozalbo D. 2003. Candida albicans TDH3 gene promotes secretion of internal invertase when expressed in Saccharomyces cerevisiae as a glyceraldehyde-3-phosphate dehydrogenase-invertase fusion protein. Yeast 20: 713-722
7. Gil M.L., Villamón E., Monteagudo C., Gozalbo D. and Martínez J.P. 1999. Clinical strains of Candida albicans express the surface antigen glyceraldehyde-3-phosphate dehydrogenase in vitro and in infected tissues. FEMS Immunol. Med. Microbiol. 23: 229-234
8. Gil-Navarro I., Gil M.L., Casanova M., Martínez J.P. and Gozalbo D. 1997. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen. J. Bacteriol. 179: 4992-4999
9. Gozalbo D., Gil-Navarro I., Azorín I., Renau-Piqueras J., Martínez J.P. and Gil M.L. 1998. The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect. Immun. 66: 2052-2059
10. Gozalbo D., Villamo7acute;n E., Roig P. and Gil M.L. 2004. Candida and candidiasis: The cell wall as a potential molecular target for antifungal therapy. Curr. Drug Targets Infect. Disord. 4: 117-135
11. Han Y., Ullrich M.A. and Cutler J.E. 1999. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. 179: 1477-1484
12. Han Y., Riesselman M.H. and Cutler J.E. 2000. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 68: 1649-1654
13. Ibrahim A.S., Spellberg B.J., Avenissian V., Fu Y., Filler S.G. and Edwards J.E. Jr. 2005. Vaccination with recombinant N-terminal domain of Alsp1 improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral immunity. Infect. Immun. 73: 999-1005
14. Martínez J.P., Gil M.L., López-Ribot J.L. and Chaffin W.L. 1998. Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 11: 121-141
15. Matthews R. and Burnie J. 2001. Antifungal antibodies: A new approach to the treatment of systemic candidiasis. Curr. Opin. Investig. Drugs 4: 472-476
16. Matthews R. and Burnie J. 2004. Recombinant antibodies: A natural partner in combinatorial antifungal therapy. Vaccine 22: 865-871
17. Montagnoli C., Sandini S., Bacci A., Romani L. and la Valle R. 2004. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med. Mycol. 42: 319-324
18. Romani L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4: 1-23
19. Sanglard D. and Odds F.C. 2002. Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2: 73-85
20. Spellberg B. and Edwards J.E. Jr. 2001. Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32: 76-102
21. Spellberg B. and Edwards J.E. Jr. 2002. The pathophysiology and treatment of Candida sepsis. Curr. Infect. Dis. Rep. 4: 387-399
22. Villamón E., Gozalbo D., Martínez J.P. and Gil M.L. 1999. Purification of a biologically active recombinant glyceraldehyde-3-phosphate dehydrogenase from Candida albicans. FEMS Microbiol. Lett. 179: 61-65
23. Villamón E., Gozalbo D., Roig P., Murciano C., O'Connor J.E., Fradelizi D. and Gil M.L. 2004. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines. Eur. Cytokine Netw. 15: 263-271
24. Zhang Z.X., Sonnerborg A. and Sallberg M. 1994. Antigenic structure of the hepatitis C virus envelope 2 protein. Clin. Exp. Immunol. 98: 382-387